1. Introduction {#sec1}
===============

Systemic inflammation triggered by bacterial endotoxin is characterized by increased cytokines, altered energy balance via suppression of food consumption and enhanced thermogenesis, body weight loss and behavioral changes [@bib1], [@bib2], [@bib3], [@bib4]. These responses and the resulting undernutrition compromise the recovery of the organism. Experimentally, the innate immune system can be activated by administration of lipopolysaccharide (LPS), a cell wall component derived from Gram-negative bacteria. LPS or cytokine injection increases the gene expression and the circulating levels of the proinflammatory adipokine leptin in rodents [@bib5], [@bib6], [@bib7]. Leptin is primarily secreted by the white adipose tissue and acts in the brain to control energy homeostasis. Leptin administration decreases food intake and increases energy expenditure [@bib8], [@bib9]. The ability of leptin to reduce food intake requires the signal transducer and activation of transcription 3 (STAT3) signaling, which in turn stimulates the transcription of the proopiomelanocortin (*Pomc*) gene, a well-known anorexigenic factor [@bib10], [@bib11].

Evidence from several studies indicates that phosphoinositide 3- kinase (PI3K) signaling is an important molecular pathway in metabolic regulation also activated by leptin [@bib12], [@bib13], [@bib14], [@bib15]. Leptin triggers PI3K activity via phosphorylation of the insulin receptor substrate-2 (IRS-2) [@bib12], [@bib16]. The regulatory subunit p85 then binds to IRS and localizes the catalytic activity to the cell membrane. The PI3K p110 catalytic subunit in turn catalyzes the phosphorylation of PIP2 (phosphatidylinositol 4,5-bisphosphate) to PIP3 (phosphatidylinositol 3,4,5-trisphosphate) that finally recruits and activates downstream molecules [@bib17]. Reports using pharmacological approaches have demonstrated that the reduction of food intake by central leptin administration is prevented by pretreatment with PI3K inhibitors [@bib12], [@bib13]. The p110α and p110β subunits are critical for the PI3K action on metabolic regulation and are important candidates to mediate leptin\'s effects [@bib18], [@bib19], [@bib20]. Genetic suppression of PI3K activity in hypothalamic neurons blocks the acute effects of leptin on cells activity [@bib21], [@bib22].

Luyendyk and coworkers [@bib23] reported that PI3K pathway negatively regulates LPS-induced responses in monocytes and macrophages. However, the role of PI3K in the hypophagia triggered by LPS remains an open question. We hypothesized that leptin-mediated PI3K signaling plays a role in LPS-induced hypophagia. To test this hypothesis, we initially used pharmacologic inhibition of PI3K in mice exposed to endotoxin. In addition, we generated mice lacking either p110α or p110α and p110β isoforms selectively in LepR cells, using the Cre-loxP system. We further assessed the metabolic changes (body weight and food intake) in response to acute LPS treatment and the activation of STAT3 and PI3K pathways. The requirement of leptin in LPS-induced hypophagia, pSTAT3 and pAKT expression was evaluated using leptin-deficient *ob/ob* mice.

2. Materials and methods {#sec2}
========================

2.1. Ethics statement {#sec2.1}
---------------------

All animal procedures were carried out with prior approval from the University of Michigan Committee on Use and Care of Animals (IACUC, Animal Protocol: PRO00004380), in accordance with the guidelines established by the National Institute of Health Guide for the Care and Use of Laboratory Animals, as well as an approval of the Ethics Committee for Animal Use of the School of Medicine of Ribeirao Preto, University of Sao Paulo.

2.2. Animals {#sec2.2}
------------

All animals were kept in a light- (12 h on/off) and temperature- (21--23 °C) controlled environment with free access to water and food. The wild type C57BL/6 (JAX^®^ mice, stock \# 000664), the *ob/ob* (JAX^®^ mice, stock \# 000632), the LepR-Cre (JAX^®^ mice, stock \# 008320), the R26-tdTomato (JAX^®^ mice, stock \# 007914), the *Pik3ca* ^*loxP/loxP*^ (JAX^®^ mice, stock \# 017704) [@bib24] and the *Pik3cb* ^*loxP/loxP*^ (JAX^®^ mice, stock \# 017705) [@bib25] mice were kept in the University of Michigan animal facility. Wild type C57BL/6 mice used for the central injection of the PI3K inhibitor were kept in the Medical School Central Animal Facility of the University of Sao Paulo - Campus of Ribeirao Preto.

In order to visualize the LepRb expressing neurons, we crossed the LepR-Cre, a knock-in strain that coexpresses Cre-recombinase with the *Lepr* gene, previously described and validated [@bib26], [@bib27], with the R26-tdTomato mouse, which have a *loxP*-flanked transcription-blocking cassette preventing the expression of CAG promoter-driven tdTomato, a red fluorescent protein. Under Cre-mediated excision of the *loxP*-flanked site, the endogenous red fluorescence is detected only in LepR cells.

2.3. LepR-specific deletion of p110α or p110α+β and genotyping {#sec2.3}
--------------------------------------------------------------

To inactivate the catalytic subunit p110α or both subunits p110α and p110β in LepRb neurons, LepR-Cre mice were crossed with mice carrying the *loxP*-modified p110α (*Pi3kca* gene) and p110β (*Pi3kcb* gene) alleles [@bib24], [@bib25]. Preliminary observations indicated that complete Cre-mediated excision is only obtained in LepR-Cre homozygous animals. Therefore, our experimental mice were those homozygous for LepR-Cre allele and homozygous for p110α allele (LepR^Δp110α^) or homozygous for pl10α and p110β alleles (LepR^Δp110α+β^), compared with their respective homozygous littermate controls, p110α^*loxP*^ and p110α + β^*loxP*^. Deletion of the p110α and p110β subunits was validated by RT-PCR in arcuate nucleus (ARC) punches from LepR^Δp110α^ and LepR^Δp110α+β^ and their respective control mice. Brains were sliced (thickness: 1.0 mm) according to coordinates from the Franklin and Paxinos mouse brain atlas [@bib28] (−1.3 mm to −2.3 mm from Bregma) and punches of the ARC were microdissected using a stainless-steel punch needle of 1.0 mm in diameter. These mouse lines were also previously used and validated [@bib22].

PCR amplification of the floxed (flanked by *loxP* sites) genomic region, combined with the PCR detection of the Cre transgene in tail-derived DNA, was performed (Sigma RED Extract-N-Amp Tissue PCR Kit -cat\# XNAT). Mice were genotyped at weaning and after experiments, using the pairs of primers described in [Table 1](#tbl1){ref-type="table"}.

2.4. Drugs and animal treatment protocol {#sec2.4}
----------------------------------------

Intraperitoneal (ip) injection of saline (0.15M NaCl, in 5 μl/g), LPS (100 μg/kg, in 5 μl/g) from Escherichia coli (Sigma, Serotype 026:B6) or leptin (Sigma, 2.5 μg/g, in 5 μl/g) was performed between 4:00--4:30 PM, 2 h before lights off. The PI3K inhibitor LY294002 (Calbiochem, 1 μg/mouse, in 3 μl) [@bib13] or its vehicle (2% DMSO in 0.15M NaCl, 3 μl) was intracerebroventricularly (icv) injected 30 min before saline or LPS injections. All procedures were performed in 8--10 weeks old male mice.

2.5. Experimental procedures {#sec2.5}
----------------------------

### 2.5.1. Food intake and body weight phenotyping {#sec2.5.1}

Intact mice (n = 6--8/group) were single housed and allowed to adapt to the cages and to handling five days prior to the experiment. On the day of the experiment, food was withdrawn at 04:00 PM and mice received the ip injection of saline or LPS. At 06:00 PM (lights off), the animals were re-fed and food consumption was measured 2, 14 and 24 h afterward. Body weight was determined immediately before the injections and 24 h later. A group of naive wild type mice treated with LPS or saline as described above was subsequently treated with intraperitoneal injection of leptin (2.5 μg/g, ip) or saline for food intake and body weight measurements.

Food intake and body weight were also assessed in wild type mice treated with central injections of the PI3K inhibitor LY294002. For this purpose, eight days before the experiment, anesthetized mice were implanted with a cannula in the lateral ventricle. On the day of the experiment, mice were ascribed to four different groups (n = 8/group): 1) Vehicle + Saline, 2) Vehicle + LPS, 3) LY294002 + Saline, 4) LY294002 + LPS. At 3:30 PM food was withdrawn and mice received an icv injection of vehicle or LY294002. At 04:00 PM, mice received the ip injection of saline or LPS, and 2 h later, the animals were re-fed and food consumption and body weight were measured as described.

### 2.5.2. Implantation of the cannula into the lateral ventricle {#sec2.5.2}

Mice were anesthetized with a mixture of ketamine (60 mg/kg) and xylazine (7.5 mg/kg) at a volume of 0.1 mL/100 g and placed in a stereotaxic instrument (Kopf, model 900). A stainless-steel guide cannula (10 mm) was implanted into the right lateral ventricle (stereotaxic coordinates: AP = −0.3 mm, LL = −1.0 mm and depth = −2.5 mm from the Bregma). The cannula was held in place using two stainless-steel screws and dental acrylic resin in the skull. To prevent occlusion of the guide cannula, a 30 gage metal wire filled the cannula. After surgery, the mice received a prophylactic injection of penicillin (50,000 U, i.p.). Eight days after mice received an icv injection of vehicle or LY294002, followed by ip injection of saline or LPS, for food consumption and body weight measurement as described.

### 2.5.3. pSTAT3 and pAKT immunostaining after LPS administration {#sec2.5.3}

To assess the co-expression of the LepRb with pSTAT3 and pAKT in response to endotoxin, homozygous LepR-Cre -- tdTomato mice were injected ip with saline or LPS (n = 3/group). Two hours later, the mice were anesthetized using isoflurane (Fluriso, Vet One) and transcardially perfused with saline, followed by 4% formaldehyde in 0.1 M phosphate buffer (PBS). Brains were dissected, post-fixed in the same fixative for 1 h, placed in PBS containing 20% sucrose and sectioned on a cryostat (30-μm sections, 5 series) in the frontal plane. Series of brain sections were later processed for pSTAT3 or pAKT immunostaining. The tdTomato red fluorescence expressed specifically in LepR cells does not require additional staining. We also used p110α^*loxP*^ and LepR^Δp110α^ mice (n = 5/group) to evaluate pAKT immunoreactivity in response to LPS. Finally, to investigate whether LPS induces pSTAT3 and pAKT expression in leptin-deficient mice, *ob/ob* mice were injected with saline or LPS (n = 3/group). Two or 4 h after treatment the mice were submitted to the above described procedures for perfusion and immunostaining.

Brain coronal sections were rinsed with PBS and nonspecific binding was prevented by immersing the sections in blocking buffer (PBS, normal donkey serum and Triton X-100) for 1 h at room temperature. The sections were incubated for 48 h at 4 °C with primary antibodies: rabbit anti-phospho STAT3 Y705 (1:2000, Cell Signaling \# 9145) or rabbit anti-phospho AKT T308 (1:1000, Cell Signaling \# 2965). After rinses, sections were incubated for 1 h with the biotinylated goat anti-rabbit secondary antibody (1:1000, Vector Labs, BA1000) and then processed using the Vectastain Elite avidin-biotin immunoperoxidase method (Vector Labs). Solutions of diaminobenzidine, nickel sulfate, and H~2~O~2~ were used to generate blue-black immunolabeling. Finally, the sections were mounted on gelatin-coated slides and coverslipped with DPX. Photomicrographs were acquired using an Axio Imager M2 microscope (Carl Zeiss). The number of pSTAT3 immunoreactive cells was obtained by counting the black (nuclear) staining from a constant area of the ARC using ImageJ^®^ software (Version 1.38, NIH, USA). Only one side of one representative section per mouse was counted.

For immunofluorescence, after incubation in primary antibody, sections were incubated for 2 h with donkey anti-rabbit conjugated with AlexaFluor 488 (1:400, Life Technologies \# A21206) secondary antibody. Sections were coverslipped with Fluoromont-G™ mounting medium (Southern Biotechnology Associates) and analyzed using a Leica confocal laser scanning microscope. The immunoreactive structures were excited using argon or helium-neon green lasers with the excitation and barrier filters set for the fluorochrome used (green), and we collected epifluorescence using a DS red filter to visualize the tdTomato protein (red). Images showing the fluorescence were obtained from sequentially acquired images of slices excited by the laser. Fluorescence images of pSTAT3 or pAKT and LepR were superposed to identify the presence of dual-labeled neurons (yellow).

### 2.5.4. Dissection of the mediobasal hypothalamus for gene or protein expression analyses {#sec2.5.4}

Mice were injected with saline or LPS (n = 5--7/group) and 2 h later were deeply anesthetized with isoflurane and euthanized by decapitation. Mediobasal hypothalamic (MBH) fragments were dissected out (thickness: 2.0 mm) from an area 1.0 mm lateral to the midline at the anterior border of the optic chiasm and the anterior border of the mammillary bodies. Tissue was processed for RT-PCR or Western blotting analyses.

### 2.5.5. Immunoblot analysis {#sec2.5.5}

Total protein from mediobasal hypothalamus (MBH) was extracted using 1% Triton-X 100, 25 mM Tris (pH 8.0), 1.5 mM EGTA, 0.5 mM EDTA and protease inhibitor cocktail (PhosphoStop, Roche) at 4 °C and 15,000 g for 30 min. Aliquots of the lysates containing 10 mg of protein were denatured in Laemmli buffer and β-mercaptoethanol (Bio-Rad) at 95 °C for 5 min. Samples were blotted onto a nitrocellulose membrane. Nonspecific binding was prevented by immersing the membranes in blocking buffer (3% BSA in Tris-buffered saline-Tween 20, TBS-T) for 60 min at room temperature. The membranes were then exposed overnight to the primary antibodies: rabbit anti-GAPDH (1:4000, Cell signaling \# 5174), rabbit anti-mTOR (1:1000, Cell Signaling \# 2972), rabbit anti-phospho mTOR S2448 (1:1000, Cell Signaling \# 2971), rabbit anti-phospho FoxO1 S256 (1:1000, Cell Signaling \# 9461), rabbit anti-AKT (1:3000, Cell Signaling \# 4691), rabbit anti-phospho AKT S473 (1:3000, Cell Signaling \# 4058) or rabbit anti-phospho AKT T308 (1:3000, Cell Signaling \# 2965). The blots were rinsed in TBS-T and then incubated with horseradish peroxidase-conjugated anti-rabbit antibody (1:4000, Cell Signaling \# 7074) for 1 h at room temperature. Antibody-antigen complexes were visualized by detecting enhanced chemiluminescence using an ECL detection system (Thermo Scientific) and digital images with Chemi Doc™ XRS^+^ Image Lab™ software (Bio-Rad). Expression of all proteins/phospho-proteins was normalized to the expression of GAPDH. Data were analyzed as relative expression (%) respective to each control mouse line.

### 2.5.6. Gene expression by real time RT-PCR {#sec2.5.6}

Total RNA was isolated from MBH or ARC punches using RNA extraction kit, Qiazol Reagent (miRNeasy, Qiagen) and DNase treatment (RNase-Free; Qiagen). The cDNA was synthesized using Superscript II and random primers (Invitrogen) according to the manufacturer\'s protocol. Quantitative real-time PCR was performed on a CFX-384 Bio-Rad RT-PCR detection system using SYBR^®^ Green Gene Expression Assays and pairs of primers designed by Sigma, as described in [Table 2](#tbl2){ref-type="table"}. All samples and standard curves were run in triplicate. Water instead of cDNA was used as a negative control. One housekeeping gene (*Gapdh*) was used for each cDNA sample. Determination of gene transcript in each sample was obtained by the ΔΔCT method [@bib29]. For each sample, the threshold cycle (Ct) of mRNA was measured and normalized to the average of the housekeeping genes (ΔCt = Ct~Unknown~ − Ct~Housekeeping\ gene~). The fold change of mRNA in the unknown sample relative to control group was determined by 2^−ΔΔCt^, where ΔΔCt = ΔCt~Unknown~ − ΔCt~Control~. Data are shown as a percentage (%) of the relative mRNA expression to the control group.

2.6. Statistical analysis {#sec2.6}
-------------------------

The results are expressed as the means ± SEM and were analyzed using the GraphPad Prism 6 software. Comparison between 2 groups (saline and LPS) was carried out using the unpaired 2-tailed Student\'s *t* test. Two-way ANOVA followed by Tukey\'s *post hoc* test was used to compare the effects of LPS treatment between mouse lines. Differences were accepted as significant at *p* \< 0.05.

3. Results {#sec3}
==========

3.1. Acute decrease in food intake and body weight after LPS or leptin treatment {#sec3.1}
--------------------------------------------------------------------------------

Wild type mice injected with LPS showed a substantial reduction in food intake and body weight from 2 to 24 h after treatment ([Figure 1](#fig1){ref-type="fig"}A--B). These responses occurred in parallel to an increase in *Pomc* gene transcription. No changes in neuropeptide Y (NPY) and agouti related protein (AgRP) mRNA expression were observed ([Figure 1](#fig1){ref-type="fig"}C). Exogenous leptin treatment promoted a reduction in food intake only 2 h after treatment, with no effect on body weight ([Figure 1](#fig1){ref-type="fig"}D--E). LPS-induced reduction of food intake was significantly higher than leptin-induced reduction of food intake over the course of 24 h. However, we did not observe an exacerbated reduction of food intake in animals treated with both LPS and exogenous leptin, suggesting a ceiling effect of LPS in the inhibition of food consumption.

3.2. Acute LPS induces pSTAT3 and pAKT in ARC LepR neurons {#sec3.2}
----------------------------------------------------------

To determine the ARC neuronal population engaged in LPS response, we used LepR-Cre -- tdTomato mice. We found that LPS significantly increased pSTAT3 expression in the ARC ([Figure 2](#fig2){ref-type="fig"}A). Around 50% of the LPS-induced STAT3 phosphorylation occurs in LepR neurons ([Figure 2](#fig2){ref-type="fig"}B). Additionally, LPS increased AKT phosphorylation in the ARC. About 78% of LPS-induced pAKT neurons in the ARC are LepR neurons ([Figure 3](#fig3){ref-type="fig"}A), indicating that endotoxin recruits both STAT3 and PI3K pathway in LepR neurons in this nucleus.

3.3. PI3K pathway is required for LPS-induced hypophagia and weight loss {#sec3.3}
------------------------------------------------------------------------

Considering the acute effect of LPS on food intake and the high localization of LPS-induced pAKT in ARC LepR neurons, we investigated the LPS effect on food intake and body weight in mice devoid of PI3K signaling by means of central injection of the PI3K inhibitor LY294002. We found that LPS treatment no longer had an effect on food intake and weight gain in wild type mice previously injected with PI3K inhibitor ([Figure 3](#fig3){ref-type="fig"}B--C), indicating that central PI3K pathway is required for the hypophagia and body weight loss induced by LPS.

3.4. PI3K p110α activity in LepR cells is not required for LPS suppression of food intake and weight loss {#sec3.4}
---------------------------------------------------------------------------------------------------------

We analyzed if the PI3K p110α catalytic subunit in LepR cells is required for the endotoxemic hypophagia using a genetic mouse model of conditional gene deletion. Mice lacking p110α in LepR cells (LepR^Δp110α^) presented a 42% reduction of the p110α mRNA expression in the ARC, compared with controls (p110α^*loxP*^) ([Figure 3](#fig3){ref-type="fig"}A). As PI3K is widely expressed, we do not expect to completely delete p110α from the entire ARC, but selectively from LepR cells. Thus, the remaining ARC p110α expression is likely to originate from neurons other than LepR. The selective p110α deletion did not affect the expression of other, non targeted, PI3K isoforms such as the p85α, p85β, p110β and p110δ ([Figure 4](#fig4){ref-type="fig"}A).

We next assessed PI3K activity in the MBH using pAKT as a read-out. We found that LPS increased AKT phosphorylation in control mice. However, the number of pAKT positive neurons in LepR^Δp110α^ mice did not reach statistical significance, compared with saline treatment, suggesting that the p110α subunit is required for full LPS-induced pAKT expression ([Figure 4](#fig4){ref-type="fig"}B--C). LPS did not affect the mTOR phosphorylation in both animal groups ([Figure 5](#fig5){ref-type="fig"}A), but it did increase the phosphorylation of the Forkhead box protein O1 (FoxO1) in p110α^*loxP*^ controls. On the other hand, LPS-induced FoxO1 phosphorylation was blunted in LepR^Δp110α^ mice ([Figure 5](#fig5){ref-type="fig"}B), suggesting that p110α in LepR cells is required for full endotoxemia-induced pFoxO1. LPS-induced pSTAT3 expression was potentiated in LepR^Δp110α^ mice, compared with p110α^*loxP*^ controls ([Figure 5](#fig5){ref-type="fig"}C).

Although LPS-induced phosphorylation of AKT and FoxO1 has been attenuated or even absent in mice with deletion of p110α in LepR neurons, the effects of LPS on food intake and body weight were similar to that found in controls treated with LPS, suggesting that p110α in LepR neurons is not required for the LPS-induced hypophagia and weight loss ([Figure 6](#fig6){ref-type="fig"}A--B).

3.5. PI3K p110β activity in LepR cells is necessary for the LPS suppression of food intake and weight loss {#sec3.5}
----------------------------------------------------------------------------------------------------------

We therefore assessed the possible contribution of the PI3K catalytic subunit p110β in LPS-induced hypophagia performing p110α and p110β subunits double deletion in LepR cells. A 38% reduction in p110α and a 35% reduction in p110β mRNA expression in ARC punches of LepR^Δp110α+β^ mice were observed respective to p110α + β^*loxP*^ littermate controls ([Figure 7](#fig7){ref-type="fig"}A). As expected, LPS increased the AKT phosphorylation in control p110α + β^*loxP*^. However, mice with the double deletion did not show changes in AKT phosphorylation in response to LPS ([Figure 7](#fig7){ref-type="fig"}B). No alteration in phospho-mTOR expression was found among groups (data not shown). FoxO1 phosphorylation was increased in p110α + β^*loxP*^ controls, but not in LepR^Δp110α+β^ mice ([Figure 7](#fig7){ref-type="fig"}C). LPS-induced STAT3 phosphorylation was equivalent between groups ([Figure 7](#fig7){ref-type="fig"}D).

Interestingly, LPS hypophagic effect was blunted in mice with deletion of both catalytic subunits p110α and p110β, whereas only a small decrease in body weight was noticed compared to control mice ([Figure 8](#fig8){ref-type="fig"}A--B), indicating that p110β isoform in LepR neurons is required for the endotoxemic hypophagia.

3.6. LPS-induced acute reduction in food intake is blunted in leptin-deficient ob/ob mice {#sec3.6}
-----------------------------------------------------------------------------------------

Studies have shown that LPS increases leptin levels [@bib5], [@bib6], [@bib7]. In orther to gain further insights into the contribution of leptin to LPS-induced hypophagia and weight loss, we next analyzed the food consumption and weight gain, as well as the STAT3 and AKT phosphorylation, in response to LPS in leptin-deficient mice (*ob/ob*). We observed that LPS failed to acutely (after 2 h) reduce food intake in *ob/ob* mice, but it did reduce food intake after 14 and 24 h. LPS treatment reduced the body weight similarly in wild type and *ob/ob* mice ([Figure 9](#fig9){ref-type="fig"}A--B). Because of lack of an acute response to LPS, we were interested to know whether LPS-induced pSTAT3 and pAKT were intact in *ob/ob* mice. In the ARC, very few pSTAT3 positive cells were detected 2 h after LPS in *ob/ob* mice and the number of pSTAT3 positive cells was significantly reduced in comparison with LPS-treated wild types at this time point ([Figure 9](#fig9){ref-type="fig"}C--D), suggesting that in the ARC, STAT3 phosphorylation in response to LPS depends at least in part on leptin signaling. Interestingly, we found an increased number of pSTAT3 positive cells in the ARC of *ob/ob* mice 4 h after LPS, compared with the initial 2 h. The number of cells expressing LPS-induced pSTAT3 at 4 h in *ob/ob* mice was higher than that in wild types treated with saline, and similar to the number found in wild types treated with LPS perfused 2 h after injection ([Figure 9](#fig9){ref-type="fig"}C--D), suggesting a delayed pSTAT3 induction by LPS in leptin-deficient mice. However, we observed very few LPS-induced pAKT in the ARC following 2 and 4 h of LPS treatment suggesting that LPS-induced pAKT requires leptin signaling.

4. Discussion {#sec4}
=============

Using pharmacological PI3K inhibitor and mouse models of selective deletion of the PI3K catalytic subunits p110α and p110β in LepR cells, we found that PI3K signaling is necessary for the acute suppression of food intake and weight loss during LPS challenges. Our findings further demonstrate that the p110β subunit, but not the p110α, in LepR expressing cells is required for the acute hypothagic response of endotoxemic mice. The role of leptin in LPS-induced AKT phosphorylation and acute hypophagia was further supported by the absence of acute (2 h) LPS-induced reduction of food intake and lack of LPS-induced AKT phosphorylation in the ARC of leptin-deficient mice. However, we found that leptin-induced pSTAT3 is not required for hypophagia in the initial stages of endotoxemia, as leptin-deficient mice showed a later food intake reduction in parallel to a delayed pSTAT3 expression in response to LPS, likely induced by inflammatory cytokines other than leptin.

As part of an effective immune response, bacterial infection induces acute hypophagia and weight loss, which initially promotes host survival given the lower energy availability to the pathogens [@bib30]. The hypophagic effects of endotoxin are primarily mediated by the actions of interleukin (IL)-1, tumor necrosis factor (TNF)-α and other cytokines generated to counteract the infection [@bib31]. A persistent hypophagic effect, however, is harmful to the organism. Hence, a useful therapy against infection could be the selective inhibition of the hypophagic response while preserving the actions of cytokines on pathogen removal. Consistent with acute bacterical infection, in this study, LPS-treated mice were lethargic in the first 2--4 h after injection. We have previously observed that rats treated with LPS (100 μg/kg, ip) show increased circulating levels of TNF-α [@bib2] and present fever from 1 to 5 h after injection [@bib32]. These findings are in agreement with data reported by Pohl and coworkers [@bib33], [@bib34] in rats. In the present study, we did not measure these parameters, but Lawrence et al. [@bib35] demonstrated that the same dose of LPS as was used in our study increased the core body temperature and the cytokine levels in parallel to a reduction in food intake in mice. We observed before that LPS increased O~2~ consumption and energy expenditure, but it did not change the respiratory quotient in rats, indicating that LPS does not affect the utilization of carbohydrates as fuel [@bib32].

LPS stimulates the secretion of the adipokine leptin [@bib5], [@bib6], [@bib7]. In a recent article, Pohl and coworkers [@bib34] showed that leptin modulates the fever response and cytokine levels induced by LPS. Treatment with leptin antibody prevents LPS-induced hypophagia and weight loss [@bib36], in agreement with our findings that leptin is a downstream mediator in the endotoxemic hypophagia. In this regard, a recent report defining the LepR neuron transcriptome [@bib37] described the gene expression of IL and TNF receptors in LepR neuronal population, evidencing that leptin responsive cells also might be responsive to molecules generated in the presence of LPS and are likely to share intracellular signaling pathways. Systemic inflammatory response to LPS alters the intestinal function [@bib38]. Recent studies by Rajala et al. [@bib39] and Sandoval [@bib40] reported that leptin regulates antimicrobial peptide-encoding genes in the gut epithelium, demonstrating that the leptin receptor signaling has a direct role in modulating the microbiota composition. In view of these findings, it should be taken into account that LPS and the subsequent secretion of leptin can act in peripheral sites that express LepR not investigated in our study, such as intestine, and this action might have an impact on energy homeostasis during endotoxemia.

Leptin-induced hypophagia is mediated by Janus kinase 2 (JAK2)/STAT3 pathway [@bib10], [@bib11], which is also activated by LPS in rodents [@bib6], [@bib41]. Our findings are in agreement with this and further demonstrate that LPS induces pSTAT3 in a subset of LepR neurons of the ARC. Because roughly half of LPS-induced pSTAT3 cells of ARC are LepR cells, LPS may induce pSTAT3 in response to ligands other than leptin. Our data indicate that LPS-induced inhibition of food intake is stronger and sustained, compared with leptin-induced inhibition in wild type naïve mice. Exogenous leptin injection following LPS treatment was not able to potentiate the hypophagic effect promoted by LPS *per se*, suggesting a ceiling effect of LPS in the inhibition of food consumption. At present, LPS-induced hypophagia in wild type mice paralleled an increase in the anorexigenic POMC and no alteration in the orexigenic NPY and AgRP mRNA expression in the hypothalamus.

Leptin promotes hypothalamic astrogenesis during development [@bib42] and it has been shown that leptin signaling in astrocytes regulates the neuronal leptin-induced STAT3 phosphorylation [@bib43]. As previous studies have shown that LepR is expressed in astrocytes [@bib42], [@bib43], our mouse model may express Cre in astrocytes as well. It is possible that the deletion of PI3K may also have occurred in astrocytes, and the effects seen in this study could be due to astrocytic response. However, in our experimental design we were not able to dissociate the effects of neurons from those of astrocytes. The participation of astrocytes in modulating food intake during endotoxemia should be addressed in future studies.

Acute suppression of food intake induced by leptin is prevented by pharmacological PI3K inhibition [@bib12], [@bib13]. Interestingly, activation of Toll like receptor 4 (TLR4) by LPS stimulates host immune response through the PI3K/AKT pathway [@bib23], [@bib44]. The major PI3K/AKT downstream substrate is FoxO1, the activity of which is inhibited through its phosphorylation by PI3K/AKT, resulting in its nuclear exclusion and attenuation of the inhibition of targeted gene expression [@bib45]. In the ARC neurons, FoxO1 located in the nucleus was shown to inhibit POMC expression, while prevented AgRP inhibition, in response to leptin [@bib46]. *In vitro* studies in microglial cells showed that LPS-induced IL-6 and TNF-α secretion were abolished by the FoxO1-specific siRNA [@bib47]. In view of these findings, we postulated that leptin could contribute to the acute LPS-induced hypophagia via activation of PI3K/AKT pathway in the hypothalamus. PI3K signaling is known to be the major stimulator of AKT phosphorylation at T308 residue, while the mammalian target of rapamycin complex 2 (mTORC2) mainly regulates AKT phosphorylation at S473 [@bib48]. In our study, LPS had no effect on mTOR and S473 AKT phosphorylation (data not shown), but it increased the AKT phosphorylation at T308 residue in ARC neurons. We found a high colocalization of pAKT T308 with LepR cells, suggesting a recruitment of PI3K pathways and potential crosstalk between leptin and LPS in PI3K activation during endotoxemia. Using a pharmacological approach, we observed that the PI3K pathway plays a role in the LPS-induced hypophagia and weight loss, given that the PI3K inhibitor prevented the LPS effects on food intake and body weight.

Since central injection of PI3K inhibitor may reach different neuronal populations, we were interested in knowing whether PI3K signaling, specifically in LepR neurons, is required for LPS-induced hypophagia. Our study revealed that both p110α and p110β subunits in LepR cells are required for the endotoxemic hypophagia and weight loss. Because lack of p110α alone had no effect in LPS suppression of food intake and weight loss, our findings indicate that the p110β subunit plays a major role. Interestingly however, deletion of p110α or of both p110α and p110β impaired the ability of LPS to phosphorylate AKT at T308 and its downstream target FoxO1, suggesting that p110 catalytic subunits in LepR neurons play a role in AKT and FoxO1 phosphorylation by the endotoxin. Although this may appear inconsistent with the physiological findings, another piece of data should be highlighted. The LepR^Δp110α^, but not the LepR^Δp110α+β^ mice, showed a potentiation of LPS-induced STAT3 phosphorylation. The molecular mechanism underlying this effect is not clear but high levels of pSTAT3 may contribute to the preserved hypophagic effect in LepR^Δp110α^ mice.

Studies using conditional p110α and p110β null mice revealed that these subunits have different contributions to the regulation of neuronal function [@bib19], [@bib20]. Leptin differentially modulates POMC and NPY/AgRP neurons in the ARC via PI3K-dependent mechanisms; i.e., it depolarizes POMC and hyperpolarizes NPY/AgRP neurons [@bib49], [@bib50], [@bib51]. Inactivating either p110α or p110β in POMC and AgRP neurons, Al-Qassab and coworkers [@bib20] demonstrated a dominant role for p110β in energy homeostasis. POMC p110β null mice show hyperphagia and central leptin unresponsiveness, while POMC p110α null mice displayed a normal central response to leptin. Our model of double deletion prevents the compensatory effects of one subunit over the other and provides a mechanistic insight that the p110β subunit is required for the hypophagia during acute inflammatory challenges.

We found that in *ob/ob* mice, LPS failed to reduce food intake only in the first 2 h of lights off. This delay of LPS to suppress food intake in leptin-deficient mice is in agreement with data from Faggioni and coworkers [@bib52] who showed that LPS administration stimulated TNF-α secretion and reduced food intake 24--72 h after treatment in *ob/ob* mice. However, no measurement of food intake in shorter intervals before 24 h was described. Because LPS-induced pSTAT3 in the ARC of *ob/ob* mice was delayed, not abrogated, leptin signaling via pSTAT3 is not required for endotoxemic suppression of food intake. However, given that *ob/ob* mice did not show increased pAKT T308 in response to LPS, leptin might be required for LPS-induced AKT phosphorylation, and this effect is likely to play a role in the acute, but not sustained, endotoxemic hypophagia. Our findings indicate that leptin mediation of the LPS-induced hypophagia is an acute effect that is required for sustained suppression of food intake, and the mechanisms of this effect might be explained by STAT3 phosphorylation induced by other inflammatory cytokines over the course of the endotoxemia ([Figure 10](#fig10){ref-type="fig"}).

5. Conclusions {#sec5}
==============

Our results contribute to the understanding of the acute hypophagia induced by endotoxin. PI3K/AKT pathway associated with TLR4 action on the immune system now is found to be equally important for the acute metabolic control during infection/inflammation. The PI3K pathway via p110β catalytic subunit in LepR neurons exerts a crucial role in the suppression of feeding in endotoxemic states. Given that in response to long term exposure to the endotoxin, the host organism develops tolerance to the pathogen, which is characterized by desensitization of several responses including cytokine secretion, fever and reduction of food intake [@bib2], [@bib6], [@bib53]. We believe that the inhibition of acute hypophagia (mediated in part by PI3K in LepR expressing cells) benefits the organism, preventing excessive undernutrition during the acute-phase response to bacterial infections.
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![**LPS- or leptin-induced hypophagia and weight loss**. A--B: Graphs showing 2, 14 and 24 h food intake and 24 h change in body weight in wild type mice treated with saline or LPS (100 μg/kg, ip). C: mRNA expression in the mediobasal hypothalamus (MBH), 2 h after treatment. D--E: Graphs showing 2, 14 and 24 h food intake and 24 h change in body weight in wild type mice treated with saline or LPS (100 μg/kg, ip), followed by treatment with saline or leptin (2.5 μg/g, ip). 2-tailed Student\'s *t* test was performed. Data are expressed as mean ± SEM. (n = 6--7). \**p* \< 0.05: Saline *vs* LPS or saline *vs* leptin; \#*p* \< 0.05: Saline + leptin *vs* LPS + leptin; \$ *p* \< 0.05: LPS + Saline *vs* Saline + leptin.](gr1){#fig1}

![**LPS-induced STAT3 phosphorylation**. A: number of pSTAT3 positive cells in hypothalamic arcuate nucleus (ARC) and B: representative photomicrographs of ARC 2 h after saline or LPS (100 μg/kg, ip) injection in LepR reporter mice (red), showing pSTAT3 expression (green). 3V = third ventricle. Scale bar: 50 μm 2-tailed Student\'s *t* test was performed. Data are expressed as mean ± SEM. (n = 6). \**p* \< 0.05: Saline *vs* LPS.](gr2){#fig2}

![**PI3K pathway is required for LPS induced hypophagia**. Top panel (A) showing representative photomicrographs of pAKT T308 expression (green) in the hypothalamic arcuate (ARC) nucleus 2 h after saline or LPS (100 μg/kg, ip) injection, in LepR reporter mice (red). 3V = third ventricle. Scale bar: 50 μm. Inset images show examples of LepR neurons co-expressing or not pAKT, 40× magnificent. Graphs showing 2, 14 and 24 h food intake (B) and 24 h changes in body weight (C) in wild type mice treated with icv injection of vehicle (2% DMSO in saline, 3 μl) or PI3K inhibitor LY294002 (1 μg/mouse, 3 μl), followed by saline or LPS (100 μg/kg, ip) injection. Two-way ANOVA followed by Tukey\'s *post hoc* test was performed. Data are expressed as mean ± SEM. (n = 8). \**p* \< 0.05: Vehicle + Saline *vs* Vehicle + LPS; a *p* \< 0.05: Vehicle + LPS vs LY294002 + LPS.](gr3){#fig3}

![**Validation of deletion of PI3K p110α catalytic subunit in LepR cells**. The percentage of relative mRNA expression in punches from the hypothalamic arcuate nucleus (ARC) of intact p110α ^*loxP*^ controls in comparison with LepR^Δp110α^ mice (A) (n = 6--7/group). The number of ARC pAKT positive cells in p110α^*loxP*^ and LepR^Δp110α^ mice 2 h after saline or LPS (100 μg/kg, ip) treatment (B) (n = 5/group). Representative photomicrographs of pAKT T308 expression (green) in the ARC of p110α^*loxP*^ and LepR^Δp110α^ mice 2 h after treatment (C). 3V = third ventricle. Scale bar: 50 μm 2-tailed Student\'s *t* test (A) and Two-way ANOVA followed by Tukey\'s *post hoc* test (B) were performed. Data are expressed as mean ± SEM. \**p* \< 0.05: p110α ^*loxP*^*vs* LepR^Δp110α^ and p110α ^*loxP*^ Saline *vs* p110α ^*loxP*^ LPS.](gr4){#fig4}

![**LPS-induced protein phosphorylation in the mediobasal hypothalamus of mice with deletion of p110α catalytic subunit in LepR cells**. Percentage of pmTOR (A), pFoxO1 (B) and pSTAT3 expression in the mediobasal hypothalamus of p110α^*loxP*^ and LepR^Δp110α^ mice 2 h after saline or LPS (100 μg/kg, ip) injection (n = 5--6/group). Two-way ANOVA followed by Tukey\'s *post hoc* test was performed. Data are expressed as mean ± SEM. (n = 5/group). \**p* \< 0.05: p110α^*loxP*^ Saline *vs* p110α^*loxP*^ LPS; a *p* \< 0.05: p110α^*loxP*^ LPS *vs* LepR^Δp110α^ LPS.](gr5){#fig5}

![**PI3K p110α catalytic subunit is not required for LPS-induced hypophagia and weight loss**. Cumulative food intake 2, 14 and 24 h (A) and 24 h changes in body weight (B) in p110α ^*loxP*^ and LepR^Δp110α^ mice treated with saline or LPS (100 μg/kg, ip). Two-way ANOVA followed by Tukey\'s *post hoc* test was performed. Data are expressed as mean ± SEM. (n = 8/group). \**p* \< 0.05: p110α ^*loxP*^ Saline *vs* p110α ^*loxP*^ LPS; \#*p* \< 0.05: LepR^Δp110α^ Saline *vs* LepR^Δp110α^ LPS.](gr6){#fig6}

![**Validation of deletion of PI3K p110α and p110β catalytic subunits in LepR cells and LPS-induced protein phosphorylation in the mediobasal hypothalamus**. A: Percentage of relative mRNA expression in punches from the hypothalamic arcuate nucleus (ARC) of intact p110α + β ^*loxP*^ and LepR^Δp110α+β^ mice. Percentage of pAKT (B), pFoxO1 (C) and pSTAT3 (D) expression in the mediobasal hypothalamus, 2 h after saline or LPS (100 μg/kg, ip) injection (n = 5 - 6/group). 2-tailed Student\'s *t* test (A) and Two-way ANOVA followed by Tukey\'s *post hoc* test (B--D) were performed. Data are expressed as mean ± SEM. (n = 8/group). \**p* \< 0.05: p110α + β^*loxP*^*vs* LepR^Δp110α+β^ and p110α + β^*loxP*^ Saline *vs* p110α + β^*loxP*^ LPS; a *p* \< 0.05: p110α + β^*loxP*^ LPS *vs* LepR^Δp110α+β^ LPS; \#*p* \< 0.05: LepR^Δp110α+β^ Saline *vs* LepR^Δp110α+β^ LPS.](gr7){#fig7}

![**PI3K p110β catalytic subunit is required for LPS-induced hypophagia and weight loss**. Cumulative food intake 2, 14 and 24 h (A) and 24 h changes in body weight (B) in p110α + β ^*loxP*^ and LepR^Δp110α+β^ mice, after saline or LPS (100 μg/kg, ip) injection. Two-way ANOVA followed by Tukey\'s *post hoc* test was performed. Data are expressed as mean ± SEM. (n = 8/group). \**p* \< 0.05: p110α + β^*loxP*^ Saline *vs* p110α + β^*loxP*^ LPS; a *p* \< 0.05: p110α + β^*loxP*^ LPS *vs* LepR^Δp110α+β^ LPS; \#*p* \< 0.05: LepR^Δp110α+β^ Saline *vs* LepR^Δp110α+β^ LPS.](gr8){#fig8}

![**Acute LPS-induced hypophagia is abolished in leptin-deficient mice**. Cumulative food intake 2, 14 and 24 h food intake (A), 24 h changes in body weight (B) and number of pSTAT3 positive cells (C) in hypothalamic arcuate nucleus (ARC) in wild type (WT) and leptin-deficient mice (*ob/ob*) treated with saline or LPS (100 μg/kg, ip), 2 and 4 h after injection. In the bottom panel (D), representative photomicrographs showing pSTAT3 expression (brown dots) or pAKT expression (green) in the ARC 2 and 4 h after saline or LPS injection, in WT and *ob/ob* mice. 3V = third ventricle. Scale bar: 50 μm. Two-way ANOVA followed by Tukey\'s *post hoc* test was performed. Data are expressed as mean ± SEM. (n = 6/group for food intake and BW measurements and n = 3/group for immunostaining). \**p* \< 0.05: WT Saline *vs* WT LPS; \#*p* \< 0.05: *ob/ob* Saline *vs ob/ob* LPS; a *p* \< 0.05: WT LPS 2 h *vs ob/ob* LPS 2 h; b *p* \< 0.05: *ob/ob* LPS 2 h *vs ob/ob* LPS 4 h.](gr9){#fig9}

![**Proposed model for PI3K and STAT3 regulation of food intake and body weight in hypothalamic cells during endotoxemia**. LPS stimulates the secretion of leptin and other cytokines in peripheral tissues. Leptin binds to its receptor in hypothalamic neurons and acutely activates the PI3K-FoxO1 pathway. Simultaneously, cytokines bind to their receptors and trigger the activation of PI3K-FoxO1 and JAK-STAT3 pathways (A). The final step in both pathways is the stimulation of the transcription of POMC, which in turn promotes reduction of food intake and body weight. Over the course of the endotoxemia, the cytokines promote a sustained activation of the JAK-STAT3 pathway, contributing to a persistent reduction of food consumption (B).](gr10){#fig10}

###### 

List of primers used for genotyping of mouse models.

  Mice           Forward                               Reverse
  -------------- ------------------------------------- -------------------------------------
  LepR cre       5′ TGCTTCTGTCCGTTTGCCGGT 3′           5′ GTGAAACAGCATTGCTGTCAC 3′
  R26-tdTomato   5′ CTGTTCCTGTACGGCATGG 3′             5′ GGCATTAAAGCAGCGTATCC 3′
  p110α floxed   5′CTGTGTAGCCTAGTTTAGAGCAACCATCTA 3′   5′CCTCTCTGAACAGTTCATGTTTGATGGTGA 3′
  p110β floxed   5′ CTCAAACTAGTGACTAGAAGCTGTGA 3′      5′ CTGATCGAGGCCATTAGAGAAGACCG 3′

###### 

List of primers used for quantitative RT-PCR.

  Gene             Forward                         Reverse
  ---------------- ------------------------------- ----------------------------------
  Pomc             5′ TGAAAACCCCCGGAAGTACG 3′      5′ ACGTTGGGGTACACCTTCAC 3′
  Npy              5′ CAGAAAACGCCCCCAGAACAAGC 3′   5′ GGCAGACTGGTTTCAGGGGATGGAT 3′
  Agrp             5′ AAGCTCAGGGCACAAGAGAC 3′      5′ CAGTGCCAACAGCAGAACAC 3′
  Gapdh            5′ GCTCATGACCACAGTCCATGC 3′     5′ GTTGGGGGGGGATAGGGCCTCTCTTG 3′
  Pik3r1 (p85α)    5′ ACATCTCAAGGGAAGAAGTG 3′      5′ GGATCAGAGAAGCCATATTTTC 3′
  Pik3r2 (p85β)    5′ TTGGAGGATCTTCTGAGTC 3′       5′ CTTACTGTAGCATTCACTGTGTC 3′
  Pik3ca (p110α)   5′ GAACCAGTAGGCAACCGTGA 3′      5′ GCTCTGCTATGAGGCGAGTT 3′
  Pik3cb (p110β)   5′ TTCTGCCCACCGGGATTTAT 3′      5′ AGTCTTCGTGTTTCGTCTTCCA 3′
  Pik3cd (p110δ)   5′ GAACAAGGCAGACATCTAAG 3′      5′ CATCCTGTTGTGTTACTTCTC 3′
